Improving Cancer Pain Management Through Teach-Back Educational Approach for Patients and Primary Caregivers: A Pilot Study

Cancer Pain Clinical Trial

Official title:

Improving Cancer Pain Management Through Teach-Back Educational Approach for Patients and Primary Caregivers: A Pilot Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05856292
• Other study ID #: TarumanagaraU
• Status: Completed
• Phase: N/A
• Start date: March 1, 2022
• Est. completion date: June 30, 2022

Study information

• Verified date: May 2023
• Source: Tarumanagara University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This randomized prospective quantitative pilot study compared teach-back method to standardized educational method in patient and caregiver to improve cancer pain management

Description:

Even though there are comprehensive guidelines for cancer pain management, pain control among cancer patients and survivors is often suboptimal due to undertreatment. According to recent studies, the addition of educational interventions could improve pain relief in cancer patients. Both patients and family caregivers play an important role in delivering cancer pain self-management, especially at home. Providing knowledge for cancer pain management with optimal intervention could improve patient and caregiver outcomes.

The Teach-back method, where patients and family caregivers are asked to repeat the instruction they've received from their health care professionals, can assess patients' understanding, repeat or modify the educational material if comprehension is not demonstrated. This pilot study compared the addition of the Teach-back method for cancer patients and their caregivers and its relation to cancer pain management.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: June 30, 2022
• Est. primary completion date: June 30, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Moderate to severe pain (pain scale 4 and above)

• =18 years old

• Signed the informed consent

• Willing to cooperate until the end of studies

• The patient is fully conscious and able to communicate well

• Cared by a family caregiver

• Family caregiver able to fully function as a caregiver

Exclusion Criteria:

• Near-death (dying) stage

• Not willing to cooperate until the end of studies

• Altered mental status and communication difficulties

Related Conditions & MeSH terms

• Cancer Pain

Intervention

Other:
• Teach Back
Standard cancer pain educational intervention enhanced with teach-back method
• Placebo
Standard cancer pain educational intervention without enhancement

Locations

Country	Name	City	State
Indonesia	Dharmais National Cancer Centre	Jakarta

Sponsors (1)

Lead Sponsor	Collaborator
Tarumanagara University

Country where clinical trial is conducted

Indonesia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Cancer pain management	Quality of cancer pain management. Patient Global Impression Change (PGIC) scale is used to measure the overall quality of life and satisfaction as a conclusion toward the intervention	one month
Secondary	Health Literacy	using Health Literacy Short Form Survey Questionnaire (HLS-EU-SQ10-IDN) to measure the change in health literacy	one month
Secondary	Pain Level	using Brief Pain Inventory (BPI) to measure the change in pain level	weekly up to one month
Secondary	Distress	using distress thermometer to measure change in distress	weekly up to one month
Secondary	Belief	using Barriers Questionnaire (BQ-13) to measure change in belief	one month